MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Solesence Stock

Solesence, Inc. Common Stock

SLSNNASDAQMarkt
US$0.90
+1.3% today

Company data

Sector
Consumer Defensive
Industry
Household & Personal Products
Country
United States
CEO
Kevin Cureton
Employees
115
Market cap
$64 M
IPO
26/11/1997

Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing…

Solesence stock: price history

16/10/25-77 %16/10/26

1D

+1.3%

1W

-11.8%

1M

+2.3%

6M

-28.0%

YTD

-43.8%

1Y

-77.0%

2Y

-44.1%

5Y

-72.6%

10Y

+25.0%

Next earnings date

Next earnings date

16/11/2026 (in 30 days)

Volatility around earnings

~34% stronger price swings than usual

Ask the agents about Solesence

Solesence stock metrics

P/E

-34.88

P/B

4.83

EV/EBITDA

916.52

RETURN ON EQUITY

-1.2%

NET MARGIN

-1.0%

DEBT/EQUITY

1.73

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

25.9%

FLOAT SHARES

18,331,837

AVG. DAILY VOLUME (30D)

29,849

Comparable stocks

Frequently asked questions about Solesence stock

What does Solesence do?

Solesence, Inc. Common Stock is a company in the Consumer Defensive sector, Household & Personal Products industry, headquartered in United States.

The CEO is Kevin Cureton, the company employs around 115 people.

The IPO was on 26/11/1997; the stock trades on NASDAQ under the ticker SLSN.

When does Solesence report next?

The next earnings date is 16/11/2026.

Around past earnings, price swings were roughly 34% stronger than usual.

Does Solesence pay a dividend?

No, Solesence currently does not pay a dividend.

Which stocks are comparable to Solesence?

Comparable stocks include Procter & Gamble Company, Colgate-Palmolive Company, Estée Lauder Companies, Kenvue, Kimberly-Clark, Church & Dwight, Clorox Company and Coty.

How can I get Solesence stock analyzed?

Clicking "Analyze stock" lets five strategies assess Solesence against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.